Chemed Co. (NYSE:CHE) Shares Sold by Fort Washington Investment Advisors Inc. OH

Fort Washington Investment Advisors Inc. OH lowered its position in Chemed Co. (NYSE:CHE - Free Report) by 2.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,755 shares of the company's stock after selling 1,143 shares during the quarter. Fort Washington Investment Advisors Inc. OH owned 0.27% of Chemed worth $24,462,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Net Worth Advisory Group increased its stake in shares of Chemed by 18.1% in the first quarter. Net Worth Advisory Group now owns 541 shares of the company's stock worth $333,000 after buying an additional 83 shares during the last quarter. SG Americas Securities LLC bought a new stake in shares of Chemed in the first quarter worth $1,250,000. GAMMA Investing LLC increased its stake in shares of Chemed by 113.4% in the first quarter. GAMMA Investing LLC now owns 271 shares of the company's stock worth $167,000 after buying an additional 144 shares during the last quarter. Harbor Capital Advisors Inc. increased its stake in shares of Chemed by 4.4% in the first quarter. Harbor Capital Advisors Inc. now owns 3,328 shares of the company's stock worth $2,048,000 after buying an additional 140 shares during the last quarter. Finally, Farther Finance Advisors LLC increased its stake in shares of Chemed by 23.0% in the first quarter. Farther Finance Advisors LLC now owns 150 shares of the company's stock worth $93,000 after buying an additional 28 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company's stock.

Insider Activity

In other news, EVP Spencer S. Lee sold 1,500 shares of the business's stock in a transaction on Friday, May 16th. The shares were sold at an average price of $577.99, for a total transaction of $866,985.00. Following the completion of the transaction, the executive vice president now owns 14,627 shares of the company's stock, valued at approximately $8,454,259.73. The trade was a 9.30% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Kevin J. Mcnamara sold 1,000 shares of the business's stock in a transaction on Monday, March 31st. The shares were sold at an average price of $615.33, for a total transaction of $615,330.00. Following the transaction, the chief executive officer now directly owns 101,679 shares of the company's stock, valued at approximately $62,566,139.07. This trade represents a 0.97% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 5,500 shares of company stock valued at $3,213,780. 3.29% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of analysts recently issued reports on the stock. Wall Street Zen upgraded shares of Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th. Royal Bank of Canada lifted their price target on shares of Chemed from $667.00 to $674.00 and gave the stock an "outperform" rating in a research note on Monday, April 28th.

Chemed Stock Up 0.3%

CHE stock traded up $1.42 during trading on Monday, hitting $552.57. 122,883 shares of the company's stock traded hands, compared to its average volume of 104,101. Chemed Co. has a 52 week low of $512.12 and a 52 week high of $623.61. The stock has a fifty day moving average price of $571.05 and a two-hundred day moving average price of $565.33. The stock has a market capitalization of $8.08 billion, a price-to-earnings ratio of 27.92, a price-to-earnings-growth ratio of 2.15 and a beta of 0.54.

Chemed (NYSE:CHE - Get Free Report) last released its earnings results on Wednesday, April 23rd. The company reported $5.63 earnings per share for the quarter, beating the consensus estimate of $5.59 by $0.04. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The firm had revenue of $646.94 million during the quarter, compared to analyst estimates of $641.78 million. During the same quarter in the previous year, the firm earned $5.20 earnings per share. The firm's revenue for the quarter was up 9.8% compared to the same quarter last year. As a group, equities research analysts expect that Chemed Co. will post 21.43 EPS for the current fiscal year.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 17th. Shareholders of record on Thursday, May 29th will be paid a dividend of $0.50 per share. The ex-dividend date is Thursday, May 29th. This represents a $2.00 annualized dividend and a yield of 0.36%. Chemed's payout ratio is 9.74%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.